BioMed Research International / 2018 / Article / Tab 1

Research Article

Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation

Table 1

Baseline characteristics of patients. Data are mean (SD). AF, atrial fibrillation; DC, direct current; CAD, coronary artery disease; PAD, peripheral arterial disease; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; LA, left atrium; LV, left ventricle.

Characteristics
Patients without T2DM ( = 102)Patients with T2DM ( = 102)

Age, years69.4 ± 7.868.9 ± 7.6NS
Gender ratio, M : F0.730.73NS
Duration of AF prior to DC cardioversion, weeks14.7 ± 8.820.3 ± 18.80.007
Previous DC cardioversion, (%)6 (5.9)3 (2.9)NS
History of smoking, (%)2 (2.0)8 (7.8)0.052
Preexisting atherosclerotic disease (CAD, stroke, and PAD), (%)45 (44.1)50 (49.0)NS
Obstructive airways diseases, (%)11 (10.8)8 (7.8)NS
Hyperlipidaemia, (%)36 (35.3)42 (41.2)NS
History of alcohol excess, (%)4 (3.9)2 (2.0)NS
ACE-inhibitor or ARB use, (%)40 (39.2)63 (61.8)0.001
Amiodarone use, (%)46 (45.1)40 (39.2)NS
Flecainide use, (%)1 (1.0)2 (2.0)NS
Sotalol use, (%)4 (3.9)4 (3.9)NS
Beta-blocker use, (%)33 (32.4)27 (26.5)NS
Calcium channel blocker use, (%)23 (22.5)33 (32.4)NS
Digoxin use, (%)29 (28.4)36 (35.3)NS
Statin use, (%)29 (28.4)32 (31.4)NS
LA size, cm4.3 ± 0.84.3 ± 0.7NS
LV ejection fraction, %56.2 ± 11.854.0 ± 12.4NS
Presence of LV hypertrophy, %14 (13.7)10 (9.8)NS
1st follow-up visit after DC cardioversion, days75.2 ± 6.974.9 ± 7.5NS

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.